158 related articles for article (PubMed ID: 24081804)
21. Prognostic role of parafibromin staining and CDC73 mutation in patients with parathyroid carcinoma: A systematic review and meta-analysis based on individual patient data.
Zhu R; Wang Z; Hu Y
Clin Endocrinol (Oxf); 2020 Apr; 92(4):295-302. PubMed ID: 31945198
[TBL] [Abstract][Full Text] [Related]
22. Atypical parathyroid adenomas: challenging lesions in the differential diagnosis of endocrine tumors.
Cetani F; Marcocci C; Torregrossa L; Pardi E
Endocr Relat Cancer; 2019 Jul; 26(7):R441-R464. PubMed ID: 31085770
[TBL] [Abstract][Full Text] [Related]
23. Parafibromin expression, single-gland involvement, and limited parathyroidectomy in familial isolated hyperparathyroidism.
Iacobone M; Barzon L; Porzionato A; Masi G; Macchi V; Marino F; Viel G; Favia G
Surgery; 2007 Dec; 142(6):984-91; discussion 984-91. PubMed ID: 18063086
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic significance of parafibromin expression in parathyroid carcinoma.
Gao Y; Wang P; Lu J; Pan B; Guo D; Zhang Z; Wang A; Zhang M; Sun J; Wang W; Liang Z
Hum Pathol; 2022 Sep; 127():28-38. PubMed ID: 35654240
[TBL] [Abstract][Full Text] [Related]
25. Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification.
Juhlin CC; Villablanca A; Sandelin K; Haglund F; Nordenström J; Forsberg L; Bränström R; Obara T; Arnold A; Larsson C; Höög A
Endocr Relat Cancer; 2007 Jun; 14(2):501-12. PubMed ID: 17639063
[TBL] [Abstract][Full Text] [Related]
26. Using a Novel Diagnostic Nomogram to Differentiate Malignant from Benign Parathyroid Neoplasms.
Silva-Figueroa AM; Bassett R; Christakis I; Moreno P; Clarke CN; Busaidy NL; Grubbs EG; Lee JE; Perrier ND; Williams MD
Endocr Pathol; 2019 Dec; 30(4):285-296. PubMed ID: 31734935
[TBL] [Abstract][Full Text] [Related]
27. Parafibromin, galectin-3, PGP9.5, Ki67, and cyclin D1: using an immunohistochemical panel to aid in the diagnosis of parathyroid cancer.
Truran PP; Johnson SJ; Bliss RD; Lennard TW; Aspinall SR
World J Surg; 2014 Nov; 38(11):2845-54. PubMed ID: 25002250
[TBL] [Abstract][Full Text] [Related]
28. Expression of HER2neu in ductal carcinoma in situ is associated with local recurrence.
Han K; Nofech-Mozes S; Narod S; Hanna W; Vesprini D; Saskin R; Taylor C; Kong I; Paszat L; Rakovitch E
Clin Oncol (R Coll Radiol); 2012 Apr; 24(3):183-9. PubMed ID: 21958729
[TBL] [Abstract][Full Text] [Related]
29. Modern experience with aggressive parathyroid tumors in a high-volume New England referral center.
Quinn CE; Healy J; Lebastchi AH; Brown TC; Stein JE; Prasad ML; Callender GG; Carling T; Udelsman R
J Am Coll Surg; 2015 Jun; 220(6):1054-62. PubMed ID: 25488353
[TBL] [Abstract][Full Text] [Related]
30. Five-year follow up of patients with gastrointestinal stromal tumor: recurrence-free survival by risk group.
Kapoor R; Khosla D; Kumar P; Kumar N; Bera A
Asia Pac J Clin Oncol; 2013 Mar; 9(1):40-6. PubMed ID: 22897235
[TBL] [Abstract][Full Text] [Related]
31. Resection of adrenocortical carcinoma liver metastasis: is it justified?
Gaujoux S; Al-Ahmadie H; Allen PJ; Gonen M; Shia J; D'Angelica M; Dematteo R; Fong Y; Blumgart L; Jarnagin WR
Ann Surg Oncol; 2012 Aug; 19(8):2643-51. PubMed ID: 22526905
[TBL] [Abstract][Full Text] [Related]
32. Parathyroid carcinoma: a 22-year experience.
Busaidy NL; Jimenez C; Habra MA; Schultz PN; El-Naggar AK; Clayman GL; Asper JA; Diaz EM; Evans DB; Gagel RF; Garden A; Hoff AO; Lee JE; Morrison WH; Rosenthal DI; Sherman SI; Sturgis EM; Waguespack SG; Weber RS; Wirfel K; Vassilopoulou-Sellin R
Head Neck; 2004 Aug; 26(8):716-26. PubMed ID: 15287039
[TBL] [Abstract][Full Text] [Related]
33. Absence of nucleolar parafibromin immunoreactivity in subsets of parathyroid malignant tumours.
Juhlin CC; Haglund F; Obara T; Arnold A; Larsson C; Höög A
Virchows Arch; 2011 Jul; 459(1):47-53. PubMed ID: 21221636
[TBL] [Abstract][Full Text] [Related]
34. Parafibromin, APC, and MIB-1 Are Useful Markers for Distinguishing Parathyroid Carcinomas From Adenomas.
Hosny Mohammed K; Siddiqui MT; Willis BC; Zaharieva Tsvetkova D; Mohamed A; Patel S; Sharma J; Weber C; Cohen C
Appl Immunohistochem Mol Morphol; 2017; 25(10):731-735. PubMed ID: 27490759
[TBL] [Abstract][Full Text] [Related]
35. Loss of parafibromin expression in a subset of parathyroid adenomas.
Juhlin C; Larsson C; Yakoleva T; Leibiger I; Leibiger B; Alimov A; Weber G; Höög A; Villablanca A
Endocr Relat Cancer; 2006 Jun; 13(2):509-23. PubMed ID: 16728578
[TBL] [Abstract][Full Text] [Related]
36. Parathyroid carcinoma, atypical parathyroid adenoma, or parathyromatosis?
Fernandez-Ranvier GG; Khanafshar E; Jensen K; Zarnegar R; Lee J; Kebebew E; Duh QY; Clark OH
Cancer; 2007 Jul; 110(2):255-64. PubMed ID: 17559137
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of Ki-67 in chemotherapy-naive breast cancer patients with 10-year follow-up.
Nishimiya H; Kosaka Y; Yamashita K; Minatani N; Kikuchi M; Ema A; Nakamura K; Waraya M; Sengoku N; Tanino H; Kuranami M; Watanabe M
Anticancer Res; 2014 Jan; 34(1):259-68. PubMed ID: 24403472
[TBL] [Abstract][Full Text] [Related]
38. Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis.
Jia Y; Wang N; Wang J; Tian H; Ma W; Wang K; Tan B; Zhang G; Yang S; Bai B; Cheng Y
Ann Surg Oncol; 2014 Jan; 21(1):329-36. PubMed ID: 23982252
[TBL] [Abstract][Full Text] [Related]
39. Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma.
Tan MH; Morrison C; Wang P; Yang X; Haven CJ; Zhang C; Zhao P; Tretiakova MS; Korpi-Hyovalti E; Burgess JR; Soo KC; Cheah WK; Cao B; Resau J; Morreau H; Teh BT
Clin Cancer Res; 2004 Oct; 10(19):6629-37. PubMed ID: 15475453
[TBL] [Abstract][Full Text] [Related]
40. THE INFLUENCE OF SURGICAL EXTENT AND PARAFIBROMIN STAINING ON THE OUTCOME OF PARATHYROID CARCINOMA: 20-YEAR EXPERIENCE FROM A SINGLE INSTITUTE.
Hu Y; Bi Y; Cui M; Zhang X; Su Z; Wang M; Hua S; Liao Q; Zhao Y
Endocr Pract; 2019 Jul; 25(7):634-641. PubMed ID: 30865538
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
